Today's Daily Dose brings you news about Moderna's progress in COVID-19 vaccine development, cancelation of FDA Panel meeting to review DBV Technologies' peanut allergy product, District Court ruling on Mallinckrodt's base date AMP for Acthar Gel and AcelRx Pharma's acquisition of Tetraphase Pharma, among others.
from RTT - Biotech https://ift.tt/2x4OygY
via IFTTT
No comments:
Post a Comment